Switching to long-acting CAB/RPV was not linked to HBV reactivation or incident infection and may be a safe therapeutic option for most patients with HIV.

A prospective evaluation of symptom change over 4 weeks for outpatients with common solid tumors: Results from E2Z02 (the SOAPP study). Background: Although universal screening for chronic HBV prior ...

HealthDay News — Hepatitis B virus (HBV) screening is recommended for patients undergoing chemotherapy, immunosuppressive therapy, or transplantation, according to research published in Hepatology.

A novel questionnaire was mailed to all practicing hematologists/oncologists, where publicly accessible online physician registries facilitated identification of ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Paul Kwo, MD, professor of medicine at Stanford University, speaks with Healio about ...

The MarketWatch News Department was not involved in the creation of this content. Hepatitis B and C Therapeutics Market Surges to US$17.02 Billion in 2024 as Innovation, National Screening Policies, ...

Please provide your email address to receive an email when new articles are posted on . Despite being the smallest virus capable of causing human disease, it is estimated that up to 80% of patients ...

A child's risk of congenital heart disease (CHD) may be related to a past hepatitis B virus (HBV) infection in either parent, according to a retrospective cohort study. Paternal preconception HBV ...